The US Centers for Disease Control and Prevention is urging hospitals to accelerate advanced testing of people they suspect may have bird flu.

Doctors should use infection control measures if a hospitalized patient has suspected, probable, or confirmed H5N1, putting the patient in an airborne infection isolation room with negative pressure, and using standard, contact, and airborne precautions with eye protection such as goggles or a face shield.

San Francisco confirmed that a child in the city became the first case of H5N1. A panel of biotech leaders discussed what options could be taken next.

H5N1, or bird flu, poses a limited risk to humans but remains a serious threat. Learn how it spreads, its symptoms, and key precautions to prevent infection.

The Centers for Disease Control and Prevention today released an advisory recommending clinicians expedite subtyping of type A influenza samples from hospitalized patients, particularly individuals in an intensive care unit.

H5N1 first human death was reported in USA. Since then, health authorities have been monitoring and cases and shave sounded alarm regarding its mutation rate.

In early December 2024, a group of researchers published an article in the journal Science, entitled "A single mutation in bovine influenza H5N1 hemagglutinin switches specificity to human receptors".

Seasonal influenza vaccines triggered protective immune responses against the H5N1 avian influenza virus primarily in younger people, indicating its potential use as a first line of defense during an eventful pandemic.

As the Centers for Disease Control and Prevention (CDC) explains, bird flu is a disease caused by the influenza A virus. At the same time, recent CDC data shows that seasonal influenza A is rising across the U.

Since early 2024, the U.S. has logged 66 human cases of H5N1. Scientists are keeping a watchful eye on the virus’s spread as we enter a new year.

The findings come at a time when outbreaks of bird flu -- a different subtype of the ... of the highly pathogenic avian influenza (HPAI) H5N1 influenza virus currently circulating

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines, including vaccines for avian flu strains, to ensure the United States is better prepared for future potential pandemics, according to a recent HHS news release.